T Cells and Macrophages Drive Pathogenesis of Immune Checkpoint Inhibitor Myocarditis

Circulation. 2024 Jan 2;149(1):67-69. doi: 10.1161/CIRCULATIONAHA.123.067189. Epub 2023 Dec 28.

Author

Daniela Čiháková¹

Affiliation

¹ Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD. W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.

PMID: 38153995
DOI: 10.1161/CIRCULATIONAHA.123.067189

No abstract available

Keywords: Editorials; T-lymphocytes; immune checkpoint inhibitors; macrophages; myocarditis.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Heart
Humans
Immune Checkpoint Inhibitors
Macrophages / pathology
Myocarditis* / pathology
T-Lymphocytes / immunology

Substances

Immune Checkpoint Inhibitors

Grants and funding